Olumiant (Baricitinib)

Baricitinib, the active ingredient in Olumiant, is a Janus kinase (JAK) inhibitor presented as a tablet for oral use. It is indicated for certain inflammatory conditions and is prescribed for adult patients.

GNH USA supplies Olumiant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olumiant acts ​  ​    ​  ​  ​   ​     ​     ​      ​ ​   ​    … - Rheumatoid arthritis:              ...   … """"  ...

Common  

[{"...":{"...":"..."}}]